Effectiveness of BCG vaccination among leprosy contacts: a cohort study

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 102, Issue 7, 2008, Pages 631-638

  Duppre N C ^a   Camacho, L A B ^a   da Cunha, S S ^b   Struchiner, C J ^a   Sales, A M ^a   Nery, J A C ^a   Sarno, E N ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

BCG; Brazil; Contact tracing; Effectiveness; Leprosy; Vaccines

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BRAZIL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; RISK ASSESSMENT; RISK REDUCTION; SCAR FORMATION; TUBERCULOID LEPROSY; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADULT; BCG VACCINE; BRAZIL; CONTACT TRACING; ENDEMIC DISEASES; FEMALE; HEALTH STATUS; HUMANS; IMMUNIZATION PROGRAMS; LEPROSY; MALE; PRACTICE GUIDELINES AS TOPIC; PROGRAM EVALUATION; RISK FACTORS; RURAL HEALTH;

EID: 44749089292     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.04.015     Document Type: Article

References (21)

1. Abel L., Cua V.V., Oberti J., Lap V.D., Due L.K., Grosset J., and Lagrange P.H. Leprosy and BCG in southern Vietnam. Lancet 335 (1990) 1536
2. Bagshawe A., Scott G.C., Russel D.A., Wigley S.C., Merianos A., and Berry G. BCG vaccination in leprosy: final results of the trial in Karimui, Papua New Guinea, 1963-1979. Bull. World Health Organ. 67 (1989) 389-399
3. Bertolli J.C., Pangi C., Frerichs R., and Halloran M.E. A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, Myanmar. Int. J. Epidemiol. 26 (1997) 888-896
4. Convit J., Sampson C., Zuñiga M., Smith P.G., Plata J., Silva J., Molina J., Pinardi M.E., Bloom B.R., and Salgado A. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results. Lancet 339 (1992) 446-450
5. Convit J., Smith P.G., Zuniga M., Sampson C., Ulrich M., Plata J.A., Silva J., Molina J., and Salgado A. BCG vaccination protects against leprosy in Venezuela: a case-control study. Int. J. Leprosy 61 (1993) 185-191
6. Cunha S.S., Rodrigues L.C., Pedrosa V., Dourado I.M., Barreto M.L., and Pereira S.M. Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon. Lepr. Rev. 75 (2004) 357-366
7. Fine, P.E.M., Carneiro, A.M., Milstein, J.B., Clements, J.C., 1999. Issues relating to the use of BCG in immunization programmes. A discussion document. http://www.who.int/vaccine_research/documents/en/bcg_vaccines.pdf [accessed December 2007].
8. Gupte M.D., Vallishayee R.S., Anantharaman D.S., Nagaraju B., Sreevatsa S., Balasubramanyam S., de Britto R.L., Elango N., Uthayakumaran N., Mahalingam V.N., Lourdusamy G., Ramalingam A., Kannan S., and Arokiasamy J. Comparative leprosy vaccine trial in south India. Ind. J. Lepr. 70 (1998) 369-388
9. Lombardi C., Pedrazzani E.S., Pedrazani J.C., Ferreira Filho O., and Zicker F. Eficacia protetora del BCG contra la lepra en São Paulo, Brasil. Bol. Of. Sanit. Panam. 119 (1995) 415-421
10. Lwin K., Sundaresan T., Gyl M.M., Bechelli L.M., Tamondong C., Garbajosa P.G., Sansarricq H., and Noordeen S.K. BCG vaccination of children against leprosy: fourteen-year findings of trial in Burma. Bull. World Health Organ. 63 (1985) 1069-1078
11. Matos H., Duppre N.C., Alvin M.F.S., Vieira L., Sarno E.N., and Struchiner C.J. Epidemiologia da hanseniase em coorte de contatos intradomiciliares no Rio de Janeiro (1987-1991). Cad. Saúde Publica 15 (1999) 533-542
12. Ministério da Saúde, 1991. Portaria n( 1.401, de 14 de Agosto de 1991. Diário Oficial da União, Brasília, 16 Agosto 1991. Seção 1, p. 16707.
13. Ministério da Saúde, 1994. Segundo informe técnico sobre vacinação/revacinação BCG. Fundação Nacional de Saúde, Centro Nacional de Epidemiologia, Coordenação Nacional de Pneumologia Sanitária, Brasília.
14. Ministério da Saúde, 2006. Nota técnica n° 66/CGPNI/DEVEP/SVS/MS. Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica, Coordenação Geral do Programa Nacional de Imunizações, Brasília - DF.
15. Ministério da Saúde, 2007. DATASUS HansWin-Módulo de Acompanhamento da Hanseníase. http://www.datasus.gov.br/tabnet/tabnet.htm [accessed May 2007].
16. Ridley D.S., and Jopling W.H. Classification of leprosy according to immunity. A five-group system. Int. J. Lepr. 34 (1966) 255-273
17. Rodrigues M.L.O., Silva S.A., Neto J.C.A., Andrade A.L.S.S., and Martelli C.M.T. Protective effect of intradermal BCG against leprosy: a case-control study in central Brazil. Int. J. Lepr. 60 (1992) 335-338
18. Vijayakumaran P., Jesudasan K., Mozhi N.M., and Samuel J.D.R. Does MDT arrest transmission of leprosy to household contacts?. Int. J. Lepr. 666 (1998) 125-130
19. WHO, 2000. The final push towards elimination of leprosy: Strategic plan 2000-2005. World Health Organization, Geneva, WHO/CDS/CPE/CEE/2000.1.
20. WHO, 2006. New case detection trends in leprosy. http://www.who.int/lep/situation/NCDetection2006.pdf [accessed March 2007].
21. Zodpey S.P., Ambadekar N.N., and Thakur A. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India. Public Health 119 (2005) 209-216